AU2043388A – Cyclic peptides as promoters of absorption on administration onto the mucosa
– Google Patents
AU2043388A – Cyclic peptides as promoters of absorption on administration onto the mucosa
– Google Patents
Cyclic peptides as promoters of absorption on administration onto the mucosa
Info
Publication number
AU2043388A
AU2043388A
AU20433/88A
AU2043388A
AU2043388A
AU 2043388 A
AU2043388 A
AU 2043388A
AU 20433/88 A
AU20433/88 A
AU 20433/88A
AU 2043388 A
AU2043388 A
AU 2043388A
AU 2043388 A
AU2043388 A
AU 2043388A
Authority
AU
Australia
Prior art keywords
denotes
amino acid
absorption
mucosa
promoters
Prior art date
1987-08-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU20433/88A
Other versions
AU608878B2
(en
Inventor
Hans Peter Merkle
Susanne Raehs
Jurgen Kurt Sandow
Rainer Schmiedel
Klaus Wirth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1987-08-07
Filing date
1988-08-05
Publication date
1989-04-20
1988-08-05
Application filed by Hoechst AG
filed
Critical
Hoechst AG
1989-04-20
Publication of AU2043388A
publication
Critical
patent/AU2043388A/en
1991-04-18
Application granted
granted
Critical
1991-04-18
Publication of AU608878B2
publication
Critical
patent/AU608878B2/en
2008-08-05
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
The invention relates to the use of aids of the general formula
AU20433/88A
1987-08-07
1988-08-05
Cyclic peptides as promoters of absorption on administration onto the mucosa
Ceased
AU608878B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
DE3726324
1987-08-07
DE19873726324
DE3726324A1
(en)
1987-08-07
1987-08-07
CYCLOPEPTIDE AS RESORPTION FOLDER IN APPLICATION TO THE MEAT
Publications (2)
Publication Number
Publication Date
AU2043388A
true
AU2043388A
(en)
1989-04-20
AU608878B2
AU608878B2
(en)
1991-04-18
Family
ID=6333298
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU20433/88A
Ceased
AU608878B2
(en)
1987-08-07
1988-08-05
Cyclic peptides as promoters of absorption on administration onto the mucosa
Country Status (19)
Country
Link
US
(1)
US5091365A
(en)
EP
(1)
EP0302466B1
(en)
JP
(1)
JP2764930B2
(en)
KR
(1)
KR970004039B1
(en)
AT
(1)
ATE69556T1
(en)
AU
(1)
AU608878B2
(en)
CA
(1)
CA1331131C
(en)
DE
(2)
DE3726324A1
(en)
DK
(1)
DK168273B1
(en)
ES
(1)
ES2038725T3
(en)
FI
(1)
FI883643A
(en)
GR
(1)
GR3003733T3
(en)
HU
(1)
HU199301B
(en)
IE
(1)
IE60871B1
(en)
IL
(1)
IL87362A0
(en)
NO
(1)
NO179094C
(en)
NZ
(1)
NZ225715A
(en)
PT
(1)
PT88192B
(en)
ZA
(1)
ZA885724B
(en)
Families Citing this family (11)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
TW274552B
(en)
*
1992-05-26
1996-04-21
Hoechst Ag
PT710243E
(en)
*
1993-06-29
2000-11-30
Ferring Bv
IMPROVED SYNTHESIS OF CYCLIC PEPTIDOS.
US5767068A
(en)
*
1997-02-13
1998-06-16
Pathogenesis Corporation
Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
IT1294191B1
(en)
*
1997-09-05
1999-03-22
Alfa Wassermann Spa
Composition for treating osteoporosis, Paget’s disease or hypercalcemia, comprises calcitonin dissolved in acidic sodium chloride solution
KR100611559B1
(en)
*
1998-05-08
2007-04-25
동아제약주식회사
Intranasal pharmaceutical compositions containing calcitonin
SE514606C2
(en)
*
1998-08-26
2001-03-19
Laekartjaenster I Vaestsverige
Drugs containing GnRH analogues for the treatment of schizophrenia
DE10014007A1
(en)
*
2000-03-22
2001-10-11
Strathmann Ag & Co
Medicament for pulmonary or intranasal administration, useful for treating withdrawal symptoms, sleeping disorders or stress, comprises delta-sleep inducing peptide
US20020141970A1
(en)
*
2001-03-05
2002-10-03
Pettit Dean K.
Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
US7812120B2
(en)
2003-03-21
2010-10-12
Par Pharmaceutical, Inc.
Nasal calcitonin formulations containing chlorobutanol
EP3445778B1
(en)
2016-04-19
2020-07-15
Griffon Pharmaceuticals International SA
Pegylated bioactive peptides and uses thereof
WO2020196315A1
(en)
*
2019-03-25
2020-10-01
国立大学法人筑波大学
Promotor for permeation into cell layer, composition for facilitating drug agent absorption, and pharmaceutical composition
Family Cites Families (10)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DE3171774D1
(en)
*
1980-03-31
1985-09-19
Teijin Ltd
Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
US4900730A
(en)
*
1981-01-14
1990-02-13
Toyo Jozo Co., Ltd.
Preparation which promotes the absorption of peptides
FR2509175B1
(en)
*
1981-03-06
1987-01-16
Toyo Jozo Kk
THERAPEUTIC PREPARATION HAVING EXCELLENT ABSORPTION PROPERTIES
JPS58140026A
(en)
*
1982-01-14
1983-08-19
Toyo Jozo Co Ltd
Pharmaceutical having improved absorbability
US4568665A
(en)
1982-06-25
1986-02-04
Mitchell David C
Protein compounds
JPS59163313A
(en)
*
1983-03-09
1984-09-14
Teijin Ltd
Peptide hormone composition for nasal administration
CA1249968A
(en)
*
1984-04-05
1989-02-14
Kazuo Kigasawa
Ointment base
US4537772A
(en)
*
1984-05-02
1985-08-27
Merck & Co., Inc.
Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
JPS6160620A
(en)
*
1984-09-03
1986-03-28
Teijin Ltd
Pharmaceutical composition containing pyroglutamic acid ester
DE3532074A1
(en)
*
1985-09-09
1987-03-12
Berlin Chemie Veb
RESORPTION AGENT FOR BIOLOGICALLY ACTIVE PEPTIDES
1987
1987-08-07
DE
DE19873726324
patent/DE3726324A1/en
not_active
Withdrawn
1988
1988-08-03
DE
DE8888112611T
patent/DE3866307D1/en
not_active
Expired – Lifetime
1988-08-03
AT
AT88112611T
patent/ATE69556T1/en
not_active
IP Right Cessation
1988-08-03
EP
EP88112611A
patent/EP0302466B1/en
not_active
Expired – Lifetime
1988-08-03
ES
ES198888112611T
patent/ES2038725T3/en
not_active
Expired – Lifetime
1988-08-04
NO
NO883468A
patent/NO179094C/en
not_active
IP Right Cessation
1988-08-04
FI
FI883643A
patent/FI883643A/en
not_active
Application Discontinuation
1988-08-04
PT
PT88192A
patent/PT88192B/en
not_active
IP Right Cessation
1988-08-04
ZA
ZA885724A
patent/ZA885724B/en
unknown
1988-08-05
IL
IL87362A
patent/IL87362A0/en
not_active
IP Right Cessation
1988-08-05
CA
CA000573914A
patent/CA1331131C/en
not_active
Expired – Lifetime
1988-08-05
US
US07/228,651
patent/US5091365A/en
not_active
Expired – Lifetime
1988-08-05
AU
AU20433/88A
patent/AU608878B2/en
not_active
Ceased
1988-08-05
JP
JP63194741A
patent/JP2764930B2/en
not_active
Expired – Lifetime
1988-08-05
DK
DK440888A
patent/DK168273B1/en
not_active
IP Right Cessation
1988-08-05
HU
HU884101A
patent/HU199301B/en
not_active
IP Right Cessation
1988-08-05
IE
IE240888A
patent/IE60871B1/en
not_active
IP Right Cessation
1988-08-05
NZ
NZ225715A
patent/NZ225715A/en
unknown
1988-08-06
KR
KR1019880010046A
patent/KR970004039B1/en
not_active
IP Right Cessation
1992
1992-02-06
GR
GR910402039T
patent/GR3003733T3/el
unknown
Also Published As
Publication number
Publication date
KR890003409A
(en)
1989-04-14
DE3726324A1
(en)
1989-02-16
JPS6466128A
(en)
1989-03-13
NZ225715A
(en)
1991-02-26
HU199301B
(en)
1990-02-28
PT88192B
(en)
1995-03-01
JP2764930B2
(en)
1998-06-11
IE882408L
(en)
1989-02-07
EP0302466B1
(en)
1991-11-21
ATE69556T1
(en)
1991-12-15
AU608878B2
(en)
1991-04-18
DE3866307D1
(en)
1992-01-02
EP0302466A1
(en)
1989-02-08
FI883643A0
(en)
1988-08-04
NO883468L
(en)
1989-02-08
DK440888D0
(en)
1988-08-05
ZA885724B
(en)
1989-04-26
KR970004039B1
(en)
1997-03-24
IL87362A0
(en)
1989-01-31
FI883643A
(en)
1989-02-08
PT88192A
(en)
1989-06-30
NO179094B
(en)
1996-04-29
CA1331131C
(en)
1994-08-02
DK168273B1
(en)
1994-03-07
GR3003733T3
(en)
1993-03-16
DK440888A
(en)
1989-02-08
HUT47599A
(en)
1989-03-28
NO883468D0
(en)
1988-08-04
ES2038725T3
(en)
1993-08-01
NO179094C
(en)
1996-08-07
IE60871B1
(en)
1994-08-24
US5091365A
(en)
1992-02-25
Similar Documents
Publication
Publication Date
Title
NZ225344A
(en)
1990-08-28
3-demethylmevalonic acid derivatives and lactones and pharmaceutical compositions; intermediates for the preparation thereof
AU571225B2
(en)
1988-04-14
Retro-inverso analogues of the bradykinin potentiating peptide bpp 5a
DE69212879T2
(en)
1997-01-23
Gastric juice-stable pharmaceutical formulations for the oral administration of bile acids
FI832355A0
(en)
1983-06-28
9- (2-HYDROXYETOXIMETYL) guanidine derivate
AU2043388A
(en)
1989-04-20
Cyclic peptides as promoters of absorption on administration onto the mucosa
ES2084579T3
(en)
1996-05-16
USE OF BUSPIRONE IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALCOHOL ABUSE.
IL105795A0
(en)
1993-09-22
Cyclopeptides and their use as absorption promoters when applied to the mucosa
JPS6438086A
(en)
1989-02-08
Mevalonic acid derivative and manufacture
YU86792A
(en)
1995-10-03
SPARFLOXACIN SOLUTION, ITS PREPARATION AND ARE SPARFLOXACINE AS A SOLUTION COMPONENT
DK408083D0
(en)
1983-09-08
ISOQUINILIN DERIVATIVES, THEIR PREPARATION AND USE
NZ232388A
(en)
1991-09-25
Thioether derivatives of aminoalkoxyphenyl compounds and pharmaceutical compositions
AU610173B2
(en)
1991-05-16
New spiro (4,5) decane derivatives, process for the preparation thereof, and pharmaceutical compositions containing them
EP0341661A3
(en)
1991-05-02
Peptide-drug compositions containing alpha-aminoboronic acid derivatives
GB2180746B
(en)
1989-09-20
Compositions for administering biologically active peptides via mucous membranes
IL81926A0
(en)
1987-11-30
Pharmaceutical compositions for the oral administration of active proteins
Legal Events
Date
Code
Title
Description
2002-03-07
MK14
Patent ceased section 143(a) (annual fees not paid) or expired
